Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 5,914,122

« Back to Dashboard
Patent 5,914,122 protects UCERIS and is included in one NDA. There has been one Paragraph IV challenge on Uceris.

This patent has ten patent family members in nine countries.

Summary for Patent: 5,914,122

Title: Stable budesonide solutions, method of preparing them and use of these solutions as enema preparations and pharmaceutical foams
Abstract:A stable budesonide solution with a pH not exceeding 6.0 in which the budesonide is dissolved in a solvent which may be water, an alcohol such as ethanol, isopropanol or propylene glycol, or a water/alcohol mixture. The solution preferably also contains a stabilizer such as sodium ethylenediaminetetraacetic acid, cyclodextrins or mixtures thereof. The stable budesonide solution is useful as the active ingredient in a rectal enema or a rectal foam.
Inventor(s): Otterbeck; Norbert (Uberlingen, DE), Kuhn; Reimund (Freiamt, DE)
Assignee: Dr. Falk Pharma GmbH (Freiburg, DE)
Application Number:08/860,136
Patent Claim Types:
see list of patent claims
Formulation; Process;
Patent Metrics:
Source: PatentQuant.com
Field: Medical technology
Back Citations: 6th percentile
Forward Citations: 14th percentile

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Valeant Pharms Intl
AEROSOL, FOAM;RECTAL205613-001Oct 7, 2014RXYes5,914,122Dec 19, 2015Y
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 5,914,122

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany44 46 891Dec 27, 1994

International Patent Family for Patent: 5,914,122

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada2205305<disabled in preview>
Denmark0794767<disabled in preview>
Germany59502928<disabled in preview>
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.